It is known from our sources When will the Corona virus vaccine to be available on market
It usually takes 10 years to make vaccine but we are try to ready corona virus vaccine within this year. This opinion was given by the scientific advisor Vijay Raghwan. The vaccine will not be available to everyone from the first day it is made.There is an important point here.
Corona vaccine can be applicable to human body within 5 to 6 months, optimistic about it: Vijay Raghavan
Vijay Raghavan the country’s scientific adviser, held a press conference in New Delhi to discuss the Corona virus vaccine.And he says it takes minimum ten years time to make a simple vaccine, but they’re trying to get vaccine ready this year.It costs between 200 and 300 million USD to build, V. Raghavan said and he also said that a total of 30 team making vaccine preparations and out of which 20 team is moving towards success.
>>>> Also Checkeds SEBA 10th Result <<<<
Some update on Covid-19 Vaccine
|Here are some updates on coronavirus vaccine development:|
|1. Moderna’s RNA vaccine status|
Moderna’s RNA vaccine is among the top front-runners in the race. It set to move into the second phase of the clinical trials in July. The company, which makes use of a novel mRNA sequence fights the infected proteins and carries instructions to the body to deploy necessary antibodies to fight against the infection.
|2. Chinese CanSino Biologics Inc vaccine update|
The medical journal, The Lancet, showed that an experimental vaccine from China’s CanSino Biologics Inc. was safe and generated an immune response. It’s too early to predict the product’s eventual success and……
|3. Novavax Covid 19 vaccine status|
Named NVX-CoV2373, Novavax’s vaccine is created using recombinant protein nanoparticle technology — a genetic-engineering technology. This technology is reportedly already being used against viruses that cause Hepatitis B and shingles.
|4. Lilly, Junshi Biosciences coronavirus vaccine update|
Shanghai Junshi Biosciences Co Ltd plans to start clinical studies to test its experimental antibody against corona in the United States and China in the second quarter of the year, with partner Eli Lilly and Co. Junshi
|5. Oxford University Covid-19 vaccine status|
ChAdOx1 nCoV-19 is made from a virus (ChAdOx1), which is a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees, that has been genetically changed so that it is impossible for it to replicate in humans.
|6. Pfizer-BNTECH vaccine update|
The pharmaceutical giant, which is co-producing the vaccine with the help of a German company, BNTECH has started the process of dosing patients. Four vaccine candidates devised out of messenger RNA (mRNA) format are being tested on volunteers to identify the most viable and suited vaccine of the four. The data is being shared with scientists in real-time. The tests are currently going on in Germany and parts of the USA.
>>>>> Also Checked Central Job In India <<<<<
The virus spreads easily and a majority of the world’s population is still vulnerable to it. A vaccine would provide some protection by training people’s immune systems to fight the virus so that they do not get sick.
What about vaccine in Indian
|Coronavirus vaccine progress in India|
|1. Ramdev’s Patanjali joins the coronavirus race|
The Patanjali group, whose flagship unit sells consumer products and ayurvedic remedies, said it has launched clinical trials on humans to find a cure for COVID-19 after receiving regulatory approvals.
|2. ICMR-Bharat Biotech vaccine status|
Vaccine maker Bharat Biotech and Thomas Jefferson University of Philadelphia signed an exclusive deal to develop a new vaccine candidate for Covid-19.
|3. Serum Institute of India (SII) vaccine update|
Pune-based Serum Institute of India (SII) is a leading contender for vaccine development. The company, which is known to produce over 10 million doses of vaccines in a year used for treating other diseases has partnered with the University of Oxford to speed up the development of a safe and affordable coronavirus vaccine.
|4. Zydus Cadila vaccine update|
The Council of Scientific & Industrial Research (CSIR), which is currently testing a “repurposed” vaccine against Covid-19 in a Phase-2 trial, is hoping to seek approval from the drug controller for its wider use against the pandemic in as early as 30 days from now, according to the scientist coordinating the effort.
Reference collect form assamese news site assam.news18 and wbsite business-standard.com
As long as the vaccine is growing as long as you stay indoors.Stay with the people in the house and caring for the people in the house.Have a good relationship with people.Maintain social distance.Follow the customs of the government .Help the helpless as much as you can but in the midst of policy rules.Take Care.